139 related articles for article (PubMed ID: 15543194)
1. Cardiac toxicity of high-dose chemotherapy.
Morandi P; Ruffini PA; Benvenuto GM; Raimondi R; Fosser V
Bone Marrow Transplant; 2005 Feb; 35(4):323-34. PubMed ID: 15543194
[TBL] [Abstract][Full Text] [Related]
2. Serum cardiac troponin I levels and ECG/Echo monitoring in breast cancer patients undergoing high-dose (7 g/m(2)) cyclophosphamide.
Morandi P; Ruffini PA; Benvenuto GM; La Vecchia L; Mezzena G; Raimondi R
Bone Marrow Transplant; 2001 Aug; 28(3):277-82. PubMed ID: 11535996
[TBL] [Abstract][Full Text] [Related]
3. [Cardiotoxicity of drugs used in oncology].
Poprach A; Petráková K; Vyskocil J; Lakomý R; Nemecek R; Kocák I; Kocáková I; Vyzula R
Klin Onkol; 2008; 21(5):288-93. PubMed ID: 19202960
[TBL] [Abstract][Full Text] [Related]
4. [The cardiac toxicity of cancer chemotherapy].
Sequeira JF; Madruga IM; Ribeiro M; Duarte PC; Ferreira DC; Sarmento JL
Acta Med Port; 1994 May; 7(5):311-8. PubMed ID: 8073908
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group.
Steinherz LJ; Graham T; Hurwitz R; Sondheimer HM; Schwartz RG; Shaffer EM; Sandor G; Benson L; Williams R
Pediatrics; 1992 May; 89(5 Pt 1):942-9. PubMed ID: 1579408
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study.
Doyle JJ; Neugut AI; Jacobson JS; Grann VR; Hershman DL
J Clin Oncol; 2005 Dec; 23(34):8597-605. PubMed ID: 16314622
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of cardiotoxicity induced by anthracyclines.
Elliott P
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S2-7. PubMed ID: 16781283
[TBL] [Abstract][Full Text] [Related]
8. Early reduction in left ventricular contractile reserve detected by dobutamine stress echo predicts high-dose chemotherapy-induced cardiac toxicity.
Civelli M; Cardinale D; Martinoni A; Lamantia G; Colombo N; Colombo A; Gandini S; Martinelli G; Fiorentini C; Cipolla CM
Int J Cardiol; 2006 Jul; 111(1):120-6. PubMed ID: 16242796
[TBL] [Abstract][Full Text] [Related]
9. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
Bustová I
Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
[TBL] [Abstract][Full Text] [Related]
10. [Cardiotoxicity of antracycline treatment in the light of new biochemical diagnostic options].
Urbanová D; Mladosievicová B
Vnitr Lek; 2007 Jun; 53(6):669-77. PubMed ID: 17702127
[TBL] [Abstract][Full Text] [Related]
11. The influence of increasing age on the deliverability and toxicity of fludarabine-based combination chemotherapy regimens in patients with indolent lymphoproliferative disorders.
Polizzotto MN; Tam CS; Milner A; Januszewicz EH; Prince HM; Westerman D; Wolf MM; Seymour JF
Cancer; 2006 Aug; 107(4):773-80. PubMed ID: 16847886
[TBL] [Abstract][Full Text] [Related]
12. Exposure to anthracyclines during childhood causes cardiac injury.
Lipshultz SE
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
[TBL] [Abstract][Full Text] [Related]
13. Cardiac toxicity from systemic cancer therapy: a comprehensive review.
Curigliano G; Mayer EL; Burstein HJ; Winer EP; Goldhirsch A
Prog Cardiovasc Dis; 2010; 53(2):94-104. PubMed ID: 20728696
[TBL] [Abstract][Full Text] [Related]
14. Cardiac troponins--biochemical markers of cardiac toxicity after cytostatic therapy.
Urbanová D; Urban L; Carter A; Maasova D; Mladosievicova B
Neoplasma; 2006; 53(3):183-90. PubMed ID: 16652186
[TBL] [Abstract][Full Text] [Related]
15. Anticancer agents and cardiotoxicity.
Ng R; Better N; Green MD
Semin Oncol; 2006 Feb; 33(1):2-14. PubMed ID: 16473642
[TBL] [Abstract][Full Text] [Related]
16. Limited cardiotoxicity after extensive thoracic surgery and intraoperative hyperthermic intrathoracic chemotherapy with doxorubicin and cisplatin.
de Bree E; van Ruth S; Schotborgh CE; Baas P; Zoetmulder FA
Ann Surg Oncol; 2007 Oct; 14(10):3019-26. PubMed ID: 17638057
[TBL] [Abstract][Full Text] [Related]
17. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
18. [Cardiotoxicity and pulmonary toxicity of chemotherapy].
Okuma K; Ariyoshi Y; Ota K
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):934-41. PubMed ID: 2188614
[TBL] [Abstract][Full Text] [Related]
19. Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T), and cyclophosphamide (C) as adjuvant therapy for high risk breast cancer.
Abu-Khalaf MM; Juneja V; Chung GG; DiGiovanna MP; Sipples R; McGurk M; Zelterman D; Haffty B; Reiss M; Wackers FJ; Lee FA; Burtness BA
Breast Cancer Res Treat; 2007 Sep; 104(3):341-9. PubMed ID: 17051423
[TBL] [Abstract][Full Text] [Related]
20. Cardiac involvement in patients with hematologic malignancies.
Allegra A; Alonci A; Russo S; Cannavò A; Penna G; D'Angelo A; Bellomo G; Musolino C
J Investig Med; 2010 Oct; 58(7):859-74. PubMed ID: 20683345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
